Accessibility Menu
Todos Medical logo

Todos Medical(OTC) TOMDF

Market Cap$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Todos Medical last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-27
Todos Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-14
1 month+0%USD 0.002026-06-26
3 month+0%USD 0.002026-04-23
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-23
3 year-99.8%USD 0.002023-07-28
5 year-100%USD 0.032021-07-28
Since inception-100%USD 0.502017-08-24

Todos Medical Financials at a Glance

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.70M

Net Income (TTM)

-$26.75M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Price

$0.00

Volume

2,216,899

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

TOMDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Todos Medical

Todos Medical Ltd. is an in vitro diagnostics company focused on developing and commercializing blood tests for early detection of cancer and Alzheimer's disease. The company utilizes innovative technologies to enhance cancer diagnostics and is actively expanding its product offerings in the healthcare sector.

Products and Services
  • Proprietary blood tests for cancer detection, including TM-B1 and TM-B2
  • Diagnostic assays like the Lymphocyte Proliferation Test (LPT)
  • Tollovid, a dietary supplement aimed at enhancing immune response
Growth Outlook
  • Recent quarterly revenue peaked at $2.19 million, indicating strong market interest
  • Strategic alliances are being formed to enhance product distribution and development
  • Ongoing clinical trials for Tollovir may expand treatment options for COVID-19
Financial Highlights
  • Trailing twelve months (TTM) revenue of $8.5 million reflects growth potential
  • Gross profit margin improved to 56% in the latest quarter
  • Operating cash flow showed a positive trend, with $651,000 generated in Q3 2022
Todos Medical Ltd. operates in a competitive healthcare landscape, focusing on innovative diagnostic solutions. The company's proprietary technologies, such as the Total Biochemical Infrared Analysis (TBIA), position it well for future growth. With a commitment to addressing critical health issues like cancer and Alzheimer's, Todos Medical is poised to capture significant market share. The recent financial performance, including a notable increase in quarterly revenue and improvements in gross profit margins, suggests a positive trajectory. Strategic partnerships and ongoing clinical trials further enhance the company's growth prospects, making it an intriguing option for investors interested in the healthcare sector.
AI Generated • Jul 25, 2026

Industry

Biotechnology

Sector

Health Care

Employees

23

CEO

Gerald E. Commissiong

Website

www.todosmedical.com

Headquarters

Tel Aviv, TA 6701203, IL

TOMDF Financials

Key Financial Metrics (TTM)

Gross Margin

56.01%

Operating Margin

-126.68%

Net Income Margin

-324.81%

Return on Equity

83.70%

Return on Capital

-343.72%

Return on Assets

-163.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.41B

Volume

2.22M

Avg. Volume

51.53K

Financials (TTM)

Gross Profit

$4.08M

Operating Income

-$8.99M

EBITDA

-$7.45M

Operating Cash Flow

-$2.67M

Capital Expenditure

$1.61M

Free Cash Flow

-$1.06M

Cash & ST Invst.

$34.00K

Total Debt

$38.35M

Todos Medical Performance Analysis

Todos Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 12,230,000N/A
20222022-12-31USD 7,695,000-37.1%
Todos Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-31-50.7%
Q22022-06-30-0.9%
Q32022-09-30-12.2%
Q42022-12-31-26.7%
Todos Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.06N/A
20222022-12-31USD -0.02-72.5%
Todos Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-3154.5%
Q22022-06-3048.3%
Q32022-09-3021.7%
Q42022-12-3125.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$1.40M

-68.5%

Gross Profit

$1.40M

-22.1%

Gross Margin

100.00%

N/A

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$200.00

N/A

Employees

7

N/A

Net Income

-$4.99M

+73.4%

EBITDA

-$1.88M

+75.8%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$34.00K

-82.0%

Total Debt

$38.35M

+20.8%

Accounts Receivable

$1.05M

-58.4%

Inventory

$1.02M

-36.3%

Long Term Debt

$33.05M

+11.2%

Short Term Debt

$5.30M

+162.0%

Return on Assets

-1.64%

N/A

Return on Invested Capital

7.49%

N/A

Free Cash Flow

$883.90K

+143.0%

Operating Cash Flow

-$796.96K

+58.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NEPTFNeptune Wellness Solutions Inc.
$0.00+0.00%
ACUSAcusphere, Inc.
$0.00+0.00%
BIOAFBioasis Technologies Inc.
$0.00+0.00%
SCRCQScripsAmerica, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About TOMDF

What is the current price of Todos Medical?

Todos Medical is trading at $0.00 per share.

What is the 52-week range for Todos Medical?

Over the past 52 weeks, Todos Medical has traded between $0.00 and $0.00.

How much debt does Todos Medical have?

As of the most recent reporting period, Todos Medical reported total debt of $38.35M.

How much cash does Todos Medical have on hand?

Todos Medical reported $34.00K in cash and cash equivalents in its most recent financial results.

What is Todos Medical’s dividend yield?

Todos Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services